4.3 Article

The βENaC-overexpressing mouse as a model of cystic fibrosis lung disease

Journal

JOURNAL OF CYSTIC FIBROSIS
Volume 10, Issue -, Pages S172-S182

Publisher

ELSEVIER
DOI: 10.1016/S1569-1993(11)60021-0

Keywords

Cystic fibrosis; Mouse Model; ENaC; Airway surface liquid; Mucus obstruction; Airway inflammation

Funding

  1. European Commission [LSMH-CT-2005-018932, MEXT-CT-2004-013666]
  2. Deutsche Forschungsgemeinschaft (DFG) [MA 2081/3-2, MA 2081/4-1]
  3. Mukoviszidose e.V. [S04/08]

Ask authors/readers for more resources

Chronic lung disease remains the major cause of morbidity and mortality of cystic fibrosis (CF) patients. Cftr mutant mice developed severe intestinal obstruction, but did not exhibit the characteristic CF ion transport defects (i.e. deficient cAMP-dependent CL- secretion and increased Na+ absorption) in the lower airways, and failed to develop CF-like lung disease. These observations led to the generation of transgenic mice with airway-specific overexpression of the epithelial Na+ channel (ENaC) as an alternative approach to mimic CF ion transport pathophysiology in the lung. Studies of the phenotype of beta ENaC-transgenic mice demonstrated that increased airway Na+ absorption causes airway surface liquid (ASL) depletion, reduced mucus transport and a spontaneous CF-like lung disease with airway mucus obstruction and chronic airway inflammation. Here, we summarize approaches that can be applied for studies of the complex in vivo pathogenesis and preclinical evaluation of novel therapeutic strategies in this model of CF lung disease. (C) 2011 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available